Physiology,
Год журнала:
2022,
Номер
37(5), С. 242 - 252
Опубликована: Июнь 6, 2022
The
intertwined
relationship
between
structure
and
function
has
been
key
to
understanding
human
organ
physiology
disease
pathogenesis.
An
organ-on-a-chip
(organ
chip)
is
a
bioengineered
microfluidic
cell
culture
device
lined
by
living
cells
tissues
that
recapitulates
organ-level
functions
in
vitro.
This
accomplished
recreating
organ-specific
tissue-tissue
interfaces
microenvironmental
biochemical
mechanical
cues
while
providing
dynamic
perfusion
through
endothelium-lined
vascular
channels.
In
this
review,
we
discuss
how
emerging
technology
contributed
the
of
lung
structure-function
relationships
at
cell,
tissue,
levels.
Lab on a Chip,
Год журнала:
2022,
Номер
22(19), С. 3579 - 3602
Опубликована: Янв. 1, 2022
The
blood-brain
barrier
(BBB)
represents
a
key
challenge
in
developing
brain-penetrating
therapeutic
molecules.
BBB
dysfunction
is
also
associated
with
the
onset
and
progression
of
various
brain
diseases.
BBB-on-a-chip
(μBBB),
an
organ-on-chip
technology,
has
emerged
as
powerful
vitro
platform
that
closely
mimics
human
microenvironments.
While
μBBB
technology
seen
wide
application
study
cancer,
its
utility
other
disease
models
("μBBB+")
less
appreciated.
Based
on
advances
evolution
for
diseases
over
last
decade,
we
propose
concept
"μBBB+"
system
summarize
major
promising
applications
pathological
studies,
personalized
medical
research,
drug
development,
multi-organ-on-chip
approaches.
We
believe
such
sophisticated
highly
tunable
further
advancement
understanding
Micromachines,
Год журнала:
2022,
Номер
13(8), С. 1200 - 1200
Опубликована: Июль 28, 2022
We
guide
the
use
of
organ-on-chip
technology
in
tissue
engineering
applications.
Organ-on-chip
is
a
form
microengineered
cell
culture
platform
that
elaborates
in-vivo
like
organ
or
microenvironments.
The
consists
microfluidic
channels,
chambers,
and
stimulus
sources
emulate
microenvironment.
These
platforms
are
typically
engraved
into
an
oxygen-permeable
transparent
material.
Fabrication
these
materials
requires
microfabrication
strategies,
including
soft
lithography,
3D
printing,
injection
molding.
Here
we
provide
overview
what
platform,
where
it
can
be
used,
composed
of,
how
fabricated,
operated.
In
connection
with
this
topic,
also
introduce
recent
applications,
different
organs
modeled
on
microscale
using
technology.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2022,
Номер
10
Опубликована: Апрель 14, 2022
Organ-on-a-chip
(OoC)
is
a
new
and
promising
technology,
which
aims
to
improve
the
efficiency
of
drug
development
realize
personalized
medicine
by
simulating
in
vivo
environment
vitro
.
Physiologically
based
pharmacokinetic
(PBPK)
modeling
believed
have
advantage
better
reflecting
absorption,
distribution,
metabolism
excretion
process
drugs
than
traditional
compartmental
or
non-compartmental
models.
The
combination
PBPK
organ-on-a-chip
provide
strong
tool
for
potential
replace
animal
testing.
This
article
provides
recent
technology
including
model
construction,
parameter
estimation
validation
strategies.
Application
on
Organ-on-a-Chip
has
been
emphasized,
considerable
progress
made.
OoC
would
become
an
essential
part
development,
other
fields.
Journal of Tissue Engineering,
Год журнала:
2022,
Номер
13
Опубликована: Янв. 1, 2022
The
Organ-on-a-Chip
(OoC)
technology
shows
great
potential
to
revolutionize
the
drugs
development
pipeline
by
mimicking
physiological
environment
and
functions
of
human
organs.
translational
value
OoC
is
further
enhanced
when
combined
with
patient-specific
induced
pluripotent
stem
cells
(iPSCs)
develop
more
realistic
disease
models,
paving
way
for
a
new
generation
patient-on-a-chip
devices.
iPSCs
differentiation
capacity
leads
invaluable
improvements
in
personalized
medicine.
Moreover,
connection
single-OoC
into
multi-OoC
or
body-on-a-chip
allows
investigate
drug
pharmacodynamic
pharmacokinetics
through
study
multi-organs
cross-talks.
need
breakthrough
thanks
this
particularly
relevant
within
field
neurodegenerative
diseases,
where
number
patients
increasing
successful
rate
discovery
worryingly
low.
In
review
we
discuss
current
iPSC-based
as
screening
models
their
implication
therapies
disorders.
AJP Gastrointestinal and Liver Physiology,
Год журнала:
2022,
Номер
323(3), С. G188 - G204
Опубликована: Июль 12, 2022
Physiologically
relevant
and
broadly
applicable
liver
cell
culture
platforms
are
of
great
importance
in
both
drug
development
disease
modeling.
Organ-on-a-chip
systems
offer
a
promising
alternative
to
conventional,
static
two-dimensional
(2-D)
cultures,
providing
much-needed
cues
such
as
perfusion,
shear
stress,
three-dimensional
(3-D)
cell-cell
communication.
However,
devices
cover
broad
range
complexity
manufacture
implementation.
In
this
review,
we
summarize
the
key
features
human
that
should
be
reflected
physiologically
liver-on-a-chip
model.
We
also
discuss
different
material
properties
producing
recent
current
progress
field,
highlighting
types
at
levels
complexity.
Pharmaceutics,
Год журнала:
2022,
Номер
14(11), С. 2301 - 2301
Опубликована: Окт. 26, 2022
There
is
an
urgent
need
for
predictive
in
vitro
models
to
improve
disease
modeling
and
drug
target
identification
validation,
especially
neurological
disorders.
Cerebral
organoids,
as
alternative
methods
vivo
studies,
appear
now
powerful
tools
decipher
complex
biological
processes
thanks
their
ability
recapitulate
many
features
of
the
human
brain.
Combining
these
innovative
with
microfluidic
technologies,
referred
brain
organoids-on-chips,
allows
us
model
microenvironment
several
neuronal
cell
types
3D.
Thus,
this
platform
opens
new
avenues
create
a
relevant
approach
preclinical
applications
neuroscience.
The
transfer
pharmaceutical
industry
discovery
stages
adoption
by
scientific
community
requires
proposition
microphysiological
systems
allowing
generation
reproducible
cerebral
organoids
high
quality
terms
structural
functional
maturation,
compatibility
automation
high-throughput
screening.
In
review,
we
will
focus
on
promising
advantages
how
combination
can
enhance
reproducibility
models.
Then,
finish
explaining
why
organoids-on-chips
could
be
considered
platforms
pharmacological
applications.
Frontiers in Bioengineering and Biotechnology,
Год журнала:
2023,
Номер
11
Опубликована: Апрель 27, 2023
Microfluidics
is
an
interdisciplinary
field
that
encompasses
both
science
and
engineering,
which
aims
to
design
fabricate
devices
capable
of
manipulating
extremely
low
volumes
fluids
on
a
microscale
level.
The
central
objective
microfluidics
provide
high
precision
accuracy
while
using
minimal
reagents
equipment.
benefits
this
approach
include
greater
control
over
experimental
conditions,
faster
analysis,
improved
reproducibility.
Microfluidic
devices,
also
known
as
labs-on-a-chip
(LOCs),
have
emerged
potential
instruments
for
optimizing
operations
decreasing
costs
in
various
industries,
including
pharmaceutical,
medical,
food,
cosmetics.
However,
the
price
conventional
prototypes
LOCs
generated
clean
room
facilities,
has
increased
demand
inexpensive
alternatives.
Polymers,
paper,
hydrogels
are
some
materials
can
be
utilized
create
microfluidic
covered
article.
In
addition,
we
highlighted
different
manufacturing
techniques,
such
soft
lithography,
laser
plotting,
3D
printing,
suitable
creating
LOCs.
selection
fabrication
techniques
will
depend
specific
requirements
applications
each
individual
LOC.
This
article
comprehensive
overview
numerous
alternatives
development
low-cost
service
industries
pharmaceuticals,
chemicals,
biomedicine.
Environment International,
Год журнала:
2023,
Номер
172, С. 107801 - 107801
Опубликована: Фев. 1, 2023
Atmospheric
pollutants,
including
particulate
matters,
nanoparticles,
bioaerosols,
and
some
chemicals,
have
posed
serious
threats
to
the
environment
human's
health.
The
lungs
are
responsible
organs
for
providing
interface
between
circulatory
system
external
environment,
where
pollutant
particles
can
deposit
or
penetrate
into
bloodstream
circulation.
Conventional
studies
decipher
mechanism
underlying
air
pollution
human
health
quite
limited,
due
lack
of
reliable
models
that
reproduce
in
vivo
features
lung
tissues
after
pollutants
exposure.
In
past
decade,
advanced
near-to-native
chips,
combining
cell
biology
with
bioengineered
technology,
present
a
new
strategy
atmospheric
assessment
narrow
gap
2D
culture
animal
models.
this
review,
key
artificial
chips
cutting-edge
technologies
chip
manufacture
introduced.
recent
progresses
exposure
summarized
highlighted.
We
further
discuss
current
challenges
future
opportunities
development
their
potential
utilities
associated
toxicity
testing
drug
screening.
Advanced Healthcare Materials,
Год журнала:
2023,
Номер
13(11)
Опубликована: Дек. 6, 2023
Organotypic
and
microphysiological
systems
(MPS)
that
can
emulate
the
molecular
phenotype
function
of
human
tissues,
such
as
liver,
are
increasingly
used
in
preclinical
drug
development.
However,
despite
their
improved
predictivity,
development
success
rates
have
remained
low
with
most
compounds
failing
clinical
phases
promising
data.
Here,
it
is
tested
whether
absorption
small
molecules
to
polymers
commonly
for
MPS
fabrication
impact
pharmacological
toxicological
assessments
contribute
high
failure
rates.
To
this
end,
identical
devices
fabricated
from
eight
different
prototypic
physicochemical
properties
analyzed.
It
found
overall
primarily
driven
by
compound
hydrophobicity
number
rotatable
bonds.
differ
>1000-fold
between
polydimethyl
siloxane
(PDMS)
being
absorptive,
whereas
polytetrafluoroethylene
(PTFE)
thiol-ene
epoxy
(TEE)
absorbed
least.
Strikingly,
organotypic
primary
liver
cultures
successfully
flagged
hydrophobic
hepatotoxins
lowly
absorbing
TEE
at
therapeutically
relevant
concentrations,
isogenic
PDMS
resistant,
resulting
false
negative
safety
signals.
Combined,
these
results
guide
selection
materials
facilitate
assays
translatability.